‘The man who saved the world’: is AstraZeneca’s boss worth his millions?
Pascal Soriot’s bonus might be deserved, but that doesn’t mean it’s necessarily wise

A free daily digest of the biggest news stories of the day - and the best features from our website
Thank you for signing up to TheWeek. You will receive a verification email shortly.
There was a problem. Please refresh the page and try again.
There can’t be many company bosses in Britain, or elsewhere in the world, “more deserving of a decent bonus this year than AstraZeneca’s Pascal Soriot”, said Ben Marlow in The Daily Telegraph. No other pharmaceutical giant pledged to produce a jab on a not-for-profit basis, and Astra’s AZD1222 has been “pivotal in turning the tide” against a disease that has infected 160 million and killed 3.3 million worldwide.
Yet, incredibly, the company’s plans to reward its French boss have encountered “a storm of protest” from shareholders aghast at plans to hike his pay package from £15.4m to a maximum of £17.8m. The “faceless” but influential Investment Association waded in with a so-called “amber-top” warning – its second highest level of alert. Institutional investors Aviva and Standard Life Aberdeen (soon to be rebranded as Abrdn) both voted against the proposals, along with 40% of other investors at this week’s AGM. So Soriot will get his bonus – but he gets an undeserved punch on the nose too.
“Seconds out. In the blue corner, the man who saved the world. In the red? A bunch of corporate governance box-tickers. Who would you want to win,” asked Alistair Osborne in The Times. In fairness, this row was “a bit more nuanced than that”. Astra has “naughtily flouted” a City rule that changes to pay policy must be “three-year, not annual” events. Moreover, bumping up Soriot’s potential bonus to 900% of his £1.33m salary is unheard of at a big FTSE 100 group, and “comes perilously close to the symbolic no-no of 1,000%”. Still, “rules are there to be broken”.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
It’s hard to argue that Soriot’s contribution isn’t worth £18m: his brave gamble on the Astra/Oxford jab “is the key reason for Britain’s faster Covid recovery”. What’s more, Astra shareholders have had £30bn of capital value since Soriot rejected Pfizer’s takeover bid in 2014. “Throwing big money at your top team might look insensitive” amid a painful pandemic, said Lee Wild of Interactive Investor on ii.co.uk – but too many executives get rewarded for failure. Pascal Soriot isn’t one of them.
Funnily enough, said Helen Thomas in the FT, “it turns out the system can’t really cope with paying for success either”. And there’s the rub, said Patrick Hosking in The Times. Executive pay is “like an arms race”, and Soriot’s 900% will set “a new benchmark” for good and poor performers alike. Astra investors had an unattractive choice between “disloyalty to a world-beating company”, and “opening the floodgates to more opportunistic, precedent-smashing, norm-flouting pay proposals”. A pity Soriot couldn’t “settle for a knighthood instead”.
Continue reading for free
We hope you're enjoying The Week's refreshingly open-minded journalism.
Subscribed to The Week? Register your account with the same email as your subscription.
Sign up to our 10 Things You Need to Know Today newsletter
A free daily digest of the biggest news stories of the day - and the best features from our website
-
Government shutdown odds spike as House GOP hardliners thwart McCarthy, spending bills
Speed Read House Speaker Kevin McCarthy's caucus is in disarray, and the US is now hurtling toward an avoidable debacle
By Peter Weber Published
-
Firefighters save confused delivery robots
Tall Tales And other stories from the stranger side of life
By Chas Newkey-Burden Published
-
'Rates have peaked'
Today's Newspapers A round-up of the headlines from the UK front pages
By The Week Staff Published
-
Inflation vs. deflation: which is worse for national economies?
Today's Big Question Lower prices may be good news for households but prolonged deflation is ‘terrible for the economy’
By The Week Staff Published
-
Debanking row: is Nigel Farage case just tip of the iceberg?
Today's Big Question Data watchdog warns banks over handling of sensitive data they hold on customers
By Chas Newkey-Burden Published
-
Two-child benefit cap: a litmus test for Keir Starmer?
Today's Big Question Labour leader prioritises ‘fiscal responsibility’ but risks party revolt over pledge to keep controversial policy
By The Week Staff Published
-
What’s causing China’s deflation crisis?
Today's Big Question Stalling post-pandemic recovery and weakening demand for exports could lead to growth spiral
By The Week Staff Published
-
Why aren’t soaring interest rates bringing down inflation?
Today's Big Question PM pins blame for stubborn inflation on fixed-rate mortgages, but economists say the picture is more nuanced
By Arion McNicoll Published
-
Who will get the blame for UK mortgage misery?
Today's Big Question As mortgage rates continue to soar, fingers have been pointed far and wide
By Arion McNicoll Published
-
Has Saudi Arabia lost control of oil prices?
Today's Big Question Kingdom goes it alone to cut production, risking tension with US and reigniting cooling inflation in Europe
By The Week Staff Published
-
Why is Royal Mail failing to deliver?
Today's Big Question The 507-year-old British institution is facing carve-up and even insolvency with decline of letter writing
By The Week Staff Published